verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 120 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-4013
Product ID 50090-4013_a2bf5a20-39fd-48c0-80fc-97b63b0ed658
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA071881
Listing Expiration 2026-12-31
Marketing Start 2018-07-20

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500904013
Hyphenated Format 50090-4013

Supplemental Identifiers

RxCUI
897666
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA071881 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 120 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (50090-4013-0)
  • 30 TABLET in 1 BOTTLE (50090-4013-2)
source: ndc

Packages (2)

Ingredients (1)

verapamil hydrochloride (120 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a2bf5a20-39fd-48c0-80fc-97b63b0ed658", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897666"], "spl_set_id": ["f00c1caf-68b6-40c1-a1fa-72d17d2cf44f"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (50090-4013-0)", "package_ndc": "50090-4013-0", "marketing_start_date": "20190102"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-4013-2)", "package_ndc": "50090-4013-2", "marketing_start_date": "20230503"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "50090-4013_a2bf5a20-39fd-48c0-80fc-97b63b0ed658", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "50090-4013", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20180720", "listing_expiration_date": "20261231"}